Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine transdermal pilot trial in post-traumatic CRPS/RSD
2005-004664-23Phase 2Completed
- Sponsor
- Leadiant Biosciences
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetyl-l-carnitine in complex regional pain syndrome (CRPS), Complex Regional Pain Syndrome Type 1 (CRPS-1) and Complex regional pain syndrome type 2, sponsored by Leadiant Biosciences. Primary endpoint: Pain progression. Started Dec 2006; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
complex regional pain syndrome (CRPS)Complex Regional Pain Syndrome Type 1 (CRPS-1)Complex regional pain syndrome type 2
Beyond the preview
Go deeper on 2005-004664-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004664-23.